Ranbaxy Pharmaceuticals Canada

Sun Pharma Canada, formerly known as Ranbaxy Pharmaceuticals Canada, is a leading provider of generic and specialty pharmaceutical products within the Canadian healthcare system. The company was integrated into Sun Pharmaceutical Industries following the global acquisition of Ranbaxy Laboratories in 2015, which was valued at approximately $4 billion. It offers a diverse portfolio of affordable medications across several therapeutic areas, including cardiology, neurology, and infectious diseases. Headquartered in Brampton, Ontario, the company serves a wide network of hospitals, pharmacies, and healthcare professionals across the country. By leveraging the extensive global R&D and manufacturing infrastructure of its parent company, Sun Pharma Canada ensures the delivery of high-quality, cost-effective treatment options to Canadian patients.